|
HPV Testing, Genotyping and Cervical Cancer |
|
Human papillomavirus (HPV) testing in conjunction with a PAP smear is recommended for women age 30 and older. Guidelines also recommend HPV testing as the preferred method of follow-up evaluation for women age 20-30 with ASC-US cytology.
In 2009, the American Society for Colposcopy and Cervical Pathology (ASCCP) released a Clinical Update about the use of HPV genotyping following the FDA approval of the Cervista™ genotyping test for HPV 16/18. The ASCCP algorithm focuses on the role of high-risk HPV 16/18 genotyping for healthcare of women 30 years of age and older.
HPV Journal Articles
Day SP, Hudson A, Mast A, Sander T, Curtis M, Olson S, Chehak L, Quigley N, Ledford J, Yen-Lieberman B, Kohn D, Quigley DI, Olson M (2009). Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center study. J Clin Virol 45 Suppl 1:S63-72.v
|
Specimen and Test Information
HPV testing and HPV genotyping testing information
